Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

EXO1 protects BRCA1-deficient cells against toxic DNA lesions

Molecular Cell(2024)10.1016/j.molcel.2023.12.039Source: DataRank Database

EXO1 protects BRCA1-deficient cells against toxic DNA lesions is a research paper published in Molecular Cell (2024). On theSindex it has a DataRank of 0. It has been cited 39 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access39 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 6.62)OA: hybridTopics (53)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Anne Schreuder ORCID,Raphael Pavani ORCID,Veronica Garzero,Sidrit Uruci ORCID,Tiemen J. Wendel ORCID

Live enrichment

PubMed:38266640 PMC:PMC12250062 OpenAlex:https://openalex.org/W4391147264

ERC

Grant: 101043815

Mechanisms at the interface of DNA damage repair and transcription

U.S. Department of Defense

Grant: W81XWH-16-1-599

U.S. Department of Defense

Grant: W81XWH-19-10652

National Cancer Institute

Grant: HHSN2612015000031

Ellison Medical Foundation

Grant: AG-SS-2633-11

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Grant: 09150182110019

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Grant: 192.039

KWF Kankerbestrijding

Grant: 13472

KWF Kankerbestrijding

Grant: BUIT 2015-7546

Intramural NIH HHS

Grant: Z99 CA999999

NCI NIH HHS

Grant: HHSN261201500003I

Intramural NIH HHS

Grant: ZIA BC010959

Intramural NIH HHS

Grant: ZIA BC010283

European Research Council

Harvard University

Leids Universitair Medisch Centrum

Alex's Lemonade Stand Foundation for Childhood Cancer

National Institutes of Health

Cancer Couch Foundation

Oncode Institute

FWCI

6.62

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://ars.els-cdn.com/content/image/1-s2.0-S1097276523010857-fx1_lrg.jpg

publisherhttps://ars.els-cdn.com/content/image/1-s2.0-S1097276523010857-fx1_lrg.jpg

publisherhttps://api.elsevier.com/content/article/PII:S1097276523010857?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1097276523010857?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.molcel.2023.12.039

Fields of Study

DNA Repair MechanismsPARP inhibition in cancer therapyCRISPR and Genetic Engineering0301 basic medicine0303 health sciences03 medical and health sciencesHumansBRCA1 ProteinBRCA2 ProteinDNA DamageDNA RepairDNA Repair EnzymesExodeoxyribonucleasesHomologous RecombinationNeoplasms

MeSH Terms

DNA DamageDNA RepairExodeoxyribonucleasesHumansNeoplasmsBRCA1 ProteinBRCA2 ProteinDNA Repair EnzymesHomologous Recombination

Keywords

Genome instabilityBiologyHomologous recombinationDNA repairCancer researchDNA damageDNAMutationMolecular biologyGeneticsCell biologyGeneCancerBRCA1Dna Double-strand Break RepairSynthetic LethalitySingle-strand AnnealingExo1BRCA2 ProteinBRCA1-deficient cells. MechanisticallyBRCA1 Proteinsingle -strand annealingdeficient cellshomologousDNA Repair EnzymesExodeoxyribonucleasesNeoplasmsHumansbreak repair pathways

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

EXO1 protects BRCA1-deficient cells against toxic DNA lesions

FAIR Checklist

Authors (19)

Funding (20 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)